Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s displayed revision/version indicator was updated from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T15:26:52.000Z thumbnail image
  2. Check
    19 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Results have been posted for the study, with corresponding QC dates noted. A PDF of the Study Protocol and Statistical Analysis Plan has been added to Study Documents.
    Difference
    1%
    Check dated 2026-03-29T00:28:23.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; the page now reflects the newer revision label.
    Difference
    0.1%
    Check dated 2026-03-21T17:04:01.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T04:13:01.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' in the Results section, replacing the previous 'No Results Posted' status.
    Difference
    0.1%
    Check dated 2026-02-20T20:25:11.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.4.1 to v3.4.2, a minor update with no changes to the study data or display. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:53:38.000Z thumbnail image

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.